Source: DGNews  |  Posted 9 years ago

By Thomas S. May
Special to DG News

BUDAPEST, HUNGARY -- September 4, 2002 -- The fall in plasma glucose levels following glucose stimulation is more rapid after repaglinide than it is after glibencamide, according to research presented here yesterday, at the 38th annual meeting of the European Association for the Study of Diabetes (EASD).

Repaglinide is a new type of insulin secretagogue, which has a similar mechanism of action to that of sulfonylurea (SU) derivatives, but has a different chemical structure.

A group of researchers led by Dr. Evertine Abbink of Nijmegen University Medical Centre, Nijmegen, The Netherlands, enrolled 12 patients with type 2 diabetes (age 62